<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">AAPS J</journal-id><journal-id journal-id-type="iso-abbrev">AAPS J</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>The AAPS journal</journal-title></journal-title-group><issn pub-type="epub">1550-7416</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10902795</article-id><article-id pub-id-type="pmcid-ver">PMC10902795.1</article-id><article-id pub-id-type="pmcaid">10902795</article-id><article-id pub-id-type="pmcaiid">10902795</article-id><article-id pub-id-type="manuscript-id">NIHMS1967922</article-id><article-id pub-id-type="pmid">36702940</article-id><article-id pub-id-type="doi">10.1208/s12248-022-00779-x</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1967922</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1967922</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Theoretical Examination Seeking Tangible Physical Meanings of Slopes and Intercepts of Plasma Concentration&#8211;Time Relationships in Minimal Physiologically Based Pharmacokinetic Models</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Jeong</surname><given-names initials="YS">Yoo-Seong</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4027-0550</contrib-id><name name-style="western"><surname>Jusko</surname><given-names initials="WJ">William J.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, NY 14214, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1"><bold>Author Contribution</bold> Yoo-Seong Jeong: conceptualization, methodology, formal analysis, investigation, data curation, writing&#8212;original draft, writing&#8212;review and editing, visualization.</p><p id="P2">William J. Jusko: conceptualization, writing&#8212;original draft, writing&#8212;review and editing, supervision, project administration, funding acquisition.</p></fn><corresp id="CR1"><label>&#9993;</label>William J. Jusko, <email>wjjusko@buffalo.edu</email></corresp><fn fn-type="COI-statement" id="FN3"><p id="P87"><bold>Conflict of Interest</bold> The authors declare no conflict of interest.</p></fn></author-notes><pub-date pub-type="epub"><day>26</day><month>1</month><year>2023</year></pub-date><pub-date pub-type="collection"><day>26</day><month>1</month><year>2023</year></pub-date><volume>25</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">456738</issue-id><fpage>19</fpage><lpage>19</lpage><pub-history><event event-type="nihms-submitted"><date><day>15</day><month>02</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>29</day><month>02</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>29</day><month>02</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 18:25:27.997"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1967922.pdf"/><abstract id="ABS1"><p id="P3">In minimal physiologically based pharmacokinetic (mPBPK) models, physiological (e.g., cardiac output) and anatomical (e.g., blood/tissue volumes) variables are utilized in the domain of differential equations (DEs) for mechanistic understanding of the plasma concentration&#8211;time relationships <inline-formula><mml:math id="M1" display="inline"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula>. Although fundamental biopharmaceutical variables in terms of distribution (e.g., <inline-formula><mml:math id="M2" display="inline"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula> and <inline-formula><mml:math id="M3" display="inline"><mml:msub><mml:mrow><mml:mi>f</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) and elimination kinetics (e.g., <inline-formula><mml:math id="M4" display="inline"><mml:mi>C</mml:mi><mml:mi>L</mml:mi></mml:math></inline-formula>) in mPBPK provide greater insights in comparison to classical compartment models, an absence of kinetic elucidation of slopes and intercepts in light of such DE model parameters hinders more intuitive appreciation of <inline-formula><mml:math id="M5" display="inline"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula>. Therefore, this study seeks the tangible physical meanings of slopes and intercepts of the plasma concentration&#8211;time relationships in one- and two-tissue mPBPK models (i.e., m2CM and m3CM), with respect to time parameters that are readily understandable in PK analyses, i.e., the mean residence (<inline-formula><mml:math id="M6" display="inline"><mml:mi>M</mml:mi><mml:mi>R</mml:mi><mml:mi>T</mml:mi></mml:math></inline-formula>) and transit (<inline-formula><mml:math id="M7" display="inline"><mml:mi>M</mml:mi><mml:mi>T</mml:mi><mml:mi>T</mml:mi></mml:math></inline-formula>) times. Utilizing the explicit equations (EEs) for the slopes, intercepts, and areas of each exponential phase in the m2CM and m3CM, we theoretically and numerically examined the limiting/boundary conditions of such kinetic properties, based on the ratio of the longest tissue <inline-formula><mml:math id="M8" display="inline"><mml:mi>M</mml:mi><mml:mi>T</mml:mi><mml:mi>T</mml:mi></mml:math></inline-formula> to the <inline-formula><mml:math id="M9" display="inline"><mml:mi>M</mml:mi><mml:mi>R</mml:mi><mml:mi>T</mml:mi></mml:math></inline-formula> in the body (i.e., <inline-formula><mml:math id="M10" display="inline"><mml:msub><mml:mrow><mml:mi>K</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>M</mml:mi><mml:mi>T</mml:mi><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi></mml:mrow></mml:msub><mml:mo>/</mml:mo><mml:mi>M</mml:mi><mml:mi>R</mml:mi><mml:msub><mml:mrow><mml:mi>T</mml:mi></mml:mrow><mml:mrow><mml:mi>B</mml:mi></mml:mrow></mml:msub></mml:math></inline-formula>) that is useful for dissecting complex PBPK systems. The kinetic contribution of the area of each exponential phase to the total drug exposure was assessed to identify the elimination phase between the terminal and non-terminal phases of the <inline-formula><mml:math id="M11" display="inline"><mml:msub><mml:mrow><mml:mi>C</mml:mi></mml:mrow><mml:mrow><mml:mi>p</mml:mi></mml:mrow></mml:msub><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:math></inline-formula> in the m2CM and m3CM. This assessment provides improved understanding of the complexities inherent in all PBPK profiles and models.</p></abstract><kwd-group><kwd>Plasma pharmacokinetic profiles</kwd><kwd>Physiologically based pharmacokinetics (PBPK)</kwd><kwd>Mean residence time</kwd><kwd>Mean transit time</kwd><kwd>Elimination phase</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>